Related Experiment Video

Updated: Mar 8, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

6.3K

Molecular profiling of intrahepatic cholangiocarcinoma: the search for new therapeutic targets

Douglas V N P Oliveira1, Shanshan Zhang2, Xin Chen2

  • 1a Biotech Research and Innovation Centre (BRIC), Department of Health and Medical Sciences , University of Copenhagen , Copenhagen N , Denmark.

Expert Review of Gastroenterology & Hepatology
|February 7, 2017
PubMed
Abstract

Insights

Molecular profiling reveals distinct subtypes of intrahepatic cholangiocarcinoma (iCCA), a lethal liver cancer. Identifying genetic alterations and pathways offers new targets for innovative therapies to improve patient outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Intrahepatic cholangiocarcinoma (iCCA) is a prevalent and highly lethal primary liver tumor.
  • Limited therapeutic options for advanced iCCA stem from an incomplete understanding of its molecular pathogenesis.

Purpose of the Study:

  • To review molecular profiling studies of iCCA.
  • To highlight techniques, diagnostic/prognostic markers, and potential therapeutic targets.

Main Methods:

  • Comprehensive literature review of molecular profiling studies in iCCA.
  • Analysis of genetic alterations, transcriptomic features, and identified biomarkers.

Main Results:

  • Molecular profiling has identified distinct iCCA subtypes with unique genetic and transcriptomic profiles.
  • Several diagnostic and prognostic markers have been discovered.
  • Specific genes and pathways amenable to targeted therapy have been elucidated.

Conclusions:

  • Molecular profiling is crucial for understanding iCCA heterogeneity.
  • Targeted therapies based on identified molecular alterations show promise for improving iCCA patient prognosis.
Keywords:
Intrahepatic cholangiocarcinoma (iCCA)molecular profilingprecision medicinesignaling pathwaystherapeutic targets

More Related Videos

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

9.6K
Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer08:12

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

6.1K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
60
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
56